Showing results (1561-1570 of 6,884) with videos related to
Sort By:
Pageof 689
Leukemia Research|June 19, 2014
Carfilzomib promotes the osteogenic differentiation potential of mesenchymal stem cells derived from myeloma patients by inhibiting notch1 activity in vitroYali Li, Jun Li, Wenzhuo Zhuang, et al.Leukemia Research|June 9, 2014
The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude miceRunhong Yu, Dao Wang, Xiuhua Ren, et al.Leukemia Research|January 28, 2014
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseasesPrashant R Tembhare, Constance M Yuan, David Venzon, et al.Leukemia Research|January 21, 2014
The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaLi Yan-Li, Gu Kang-Sheng, Pan Yue-Yin, et al.Leukemia Research|January 22, 2014
Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimenJoseph M Brandwein, Eshetu G Atenafu, Andre C Schuh, et al.Leukemia Research|June 18, 2014
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemiaAlessandro Gozzetti, Veronica Candi, Alberto Fabbri, et al.Leukemia Research|January 1, 1989
Synergistic effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on the generation of DNA strand breaks in a human promyelocytic leukemia cell lineA Tanizawa, M Kubota, T Takimoto, et al.Leukemia Research|June 25, 2014
Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AMLFelix S Lichtenegger, Robin Lorenz, Katharina Gellhaus, et al.Leukemia Research|July 1, 2014
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMCB D Hock, S A Macpherson, L J Fernyhough, et al.Leukemia Research|January 1, 1989
IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurinY Yamada, Y Natsumeda, Y Yamaji, et al.Pageof 689